| Trial ID: | L6176 |
| Source ID: | NCT02102737
|
| Associated Drug: |
6-Dig
|
| Title: |
Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique
|
| Acronym: |
GLUCIMAG2
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Insulin Resistance|Glucose Metabolism Disorders|Metabolic Diseases|Endocrine System Diseases
|
| Interventions: |
DRUG: 6-DIG|PROCEDURE: clamp
|
| Outcome Measures: |
Primary: Correlation between measure of insulin resistance measurement by scintigraphy and hyperinsulinemic euglycemic clamp, Correlation between measure of insulin resistance measurement by scintigraphy (insulin resistance index: ratio scintigraphy measurement of glucose transport in heart before and after infusion of insulin) and hyperinsulinemic euglycemic clamp (Glucose Infusion Rate and sensibility index Clamp), DAY 1 AND DAY 2 | Secondary: SAFETY, A systematic collection of adverse events, visit 2, visit 3 and visit 4|Reproducibility, Reproducibility inter and intra operator of Insulin resistance index, day 2 and day 3|Left ventricule ejection fraction, day 2|left ventricle volume, day 2|cardiac mass, day 2|diastolic function, day 2|cardiac output, day 2|pulmonary pressure and right ventricular function, day 2|strain by speckle tracking echocardiography, day 2
|
| Sponsor/Collaborators: |
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2014-05-13
|
| Completion Date: |
2018-03
|
| Results First Posted: |
|
| Last Update Posted: |
2021-08-26
|
| Locations: |
Hôpital Michallon . CHU Grenoble, Grenoble, 38043, France
|
| URL: |
https://clinicaltrials.gov/show/NCT02102737
|
